To this end, and after the successful individual development of both individual MM-based aptassays for PCT [40] and IL-6 [41], here we report for the first time, an MM-based dual aptassay for the simultaneous determination of PCT and IL-6, as highly relevant early sepsis biomarkers for the sake of moving forward a multiplexed diagnosis of sepsis in special patients such as neonates. The gene discussed is IL6; the disease is Sepsis.